Condition
C-Section
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
Early P 1 (1)
P 4 (1)
Trial Status
Completed3
Not Yet Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05505110Early Phase 1RecruitingPrimary
MOdification Of THe Early-Life Respiratory Microbiome Through Vaginal SEEDing
NCT06622707Not ApplicableNot Yet RecruitingPrimary
EFFECT OF KINESIO TAPING ON POST-C-SECTION PAIN AND COMFORT
NCT02727452Not ApplicableCompletedPrimary
Immediate Bonding and Caesarean Section
NCT03176459Phase 4CompletedPrimary
Evaluate the Safety and Efficacy of EXPAREL When Administered Via Infiltration Into the TAP vs. Bupivacaine Alone in Subjects Undergoing Elective C-Sections
NCT03834415Not ApplicableCompletedPrimary
Lactobacillus Reuteri DSM17938 in C-Section Infants
Showing all 5 trials